CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|||
Property and other revenues | ||||||
Resident fee income | $ 11,839,000 | $ 10,958,000 | $ 23,689,000 | $ 21,713,000 | ||
Rental income | 38,568,000 | 34,277,000 | 75,567,000 | 66,836,000 | ||
Other revenue | 1,096,000 | 139,000 | 1,815,000 | 157,000 | ||
Total property and other revenues | 51,503,000 | 45,374,000 | 101,071,000 | 88,706,000 | ||
Expenses | ||||||
Property operating expenses | 35,026,000 | 33,230,000 | 70,103,000 | 66,124,000 | ||
Interest expense | 11,534,000 | 10,554,000 | 22,893,000 | 20,863,000 | ||
Transaction costs | 0 | 0 | 97,000 | 0 | ||
Asset management fees - related party | 0 | 2,457,000 | 0 | 5,104,000 | ||
General and administrative expenses | 3,593,000 | 3,755,000 | 7,503,000 | 7,441,000 | ||
Depreciation and amortization | 9,808,000 | 9,540,000 | 19,457,000 | 19,463,000 | ||
Impairment loss | 43,422,000 | 13,002,000 | 43,422,000 | 13,002,000 | ||
Total expenses | 103,383,000 | 72,538,000 | 163,475,000 | 131,997,000 | ||
Other income (loss) | ||||||
Other income, net | 70,000 | 5,000 | 202,000 | 77,000 | ||
Realized gain (loss) on investments and other | (4,647,000) | (252,000) | (4,315,000) | 335,000 | ||
Income (loss) before equity in earnings (losses) of unconsolidated ventures and income tax expense | (56,457,000) | (27,411,000) | (66,517,000) | (42,879,000) | ||
Equity in earnings (losses) of unconsolidated ventures | (2,546,000) | 34,053,000 | (6,468,000) | 36,555,000 | ||
Income tax expense | (11,000) | (15,000) | (26,000) | (30,000) | ||
Net income (loss) | (59,014,000) | 6,627,000 | (73,011,000) | (6,354,000) | ||
Net (income) loss attributable to non-controlling interests | 1,233,000 | 180,000 | 1,304,000 | 225,000 | ||
Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders | (57,781,000) | 6,807,000 | (71,707,000) | (6,129,000) | ||
Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders | $ (57,781,000) | $ 6,807,000 | $ (71,707,000) | $ (6,129,000) | ||
Net income (loss) per share of common stock, basic (in dollars per share) | [1] | $ (0.30) | $ 0.04 | $ (0.37) | $ (0.03) | |
Net income (loss) per share of common stock, diluted (in dollars per share) | [1] | $ (0.30) | $ 0.04 | $ (0.37) | $ (0.03) | |
Weighted average number of shares of common stock outstanding, basic (in shares) | [1] | 193,156,094 | 194,044,709 | 194,282,546 | 193,708,466 | |
Weighted average number of shares of common stock outstanding, diluted (in shares) | [1] | 193,156,094 | 194,044,709 | 194,282,546 | 193,708,466 | |
Distributions declared per share of common stock (in dollars per share) | $ 0 | $ 0.50 | $ 0 | $ 0.50 | ||
|
X | ||||||||||
- Definition Other Income (Expense) [Abstract] No definition available.
|
X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Costs of sales and operating expenses for the period incurred from transactions with related parties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|